Recruiting
Type 2 diabetes mellitus
RecruitingA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
Registered drug
A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
Registered drug
- Disease:Type 2 diabetes mellitus
- Substances:AZD5004Dapagliflozin
Countries:
Slovakia
Slovakia- Participants:18–64 years · 65+ years
- Substances:AZD5004
- Sponsor:AstraZeneca AB



